InsiderClue
Insiders · Profile

Weber Barbara

Director, Executive Chair at Tango Therapeutics · Director at Revolution Medicines. Filing since 12 Aug 2020. CIK 0001800670

TNGX Tango Therapeutics, Inc. Director, Executive Chair · 5 trades RVMD Revolution Medicines, Inc. Director · 10 trades
Company
Date
Role
Action
Shares
Amount
Of holding
TNGX Tango Therapeutics, Inc.
3 Feb 2026
Director, Executive Chair
Sold at will
30,519
$374.29K
1.8%
TNGX Tango Therapeutics, Inc.
5 Feb 2025
Chief Executive Officer
Sold at will
9,013
$28.49K
0.6%
TNGX Tango Therapeutics, Inc.
4 Feb 2025
Chief Executive Officer
Sold at will
9,778
$29.22K
0.6%
RVMD Revolution Medicines, Inc.
8 Oct 2024
Director
Sold on a plan
5,200
$249.72K
28.5%
TNGX Tango Therapeutics, Inc.
7 Feb 2024
Chief Executive Officer
Sold at will
4,457
$56.25K
0.3%
TNGX Tango Therapeutics, Inc.
6 Feb 2024
Chief Executive Officer
Sold at will
4,681
$58.81K
0.3%
RVMD Revolution Medicines, Inc.
1 Sep 2023
Director
Sold at will
15,000
$526.00K
48.7%
RVMD Revolution Medicines, Inc.
4 Feb 2021
Director
Sold, plan not stated
5,000
$251.77K
73.4%
RVMD Revolution Medicines, Inc.
2 Feb 2021
Director
Sold, plan not stated
5,336
$240.12K
74.7%
RVMD Revolution Medicines, Inc.
30 Dec 2020
Director
Sold, plan not stated
5,336
$218.53K
74.7%
RVMD Revolution Medicines, Inc.
5 Oct 2020
Director
Sold, plan not stated
7,196
$260.31K
79.9%
RVMD Revolution Medicines, Inc.
2 Oct 2020
Director
Sold, plan not stated
804
$28.96K
30.8%
RVMD Revolution Medicines, Inc.
1 Oct 2020
Director
Sold, plan not stated
2,000
$69.52K
52.5%
RVMD Revolution Medicines, Inc.
13 Aug 2020
Director
Sold, plan not stated
333
$9.32K
15.6%
RVMD Revolution Medicines, Inc.
12 Aug 2020
Director
Sold, plan not stated
1,667
$46.68K
48.0%
15 decisions on file.